| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALNY | Common Stock | Award | $0 | +3.28K | +32.82% | $0.00 | 13.3K | Jun 24, 2024 | Direct | F1 |
| transaction | ALNY | Common Stock | Sale | -$13.1K | -59 | -0.44% | $221.71 | 13.2K | Jun 25, 2024 | Direct | F2, F3 |
| transaction | ALNY | Common Stock | Sale | -$2.91K | -13 | -0.1% | $224.17 | 13.2K | Jun 25, 2024 | Direct | F2, F4 |
| transaction | ALNY | Common Stock | Sale | -$4.06K | -18 | -0.14% | $225.55 | 13.2K | Jun 25, 2024 | Direct | F2, F5 |
| transaction | ALNY | Common Stock | Sale | -$7.71K | -34 | -0.26% | $226.82 | 13.1K | Jun 25, 2024 | Direct | F2, F6 |
| transaction | ALNY | Common Stock | Sale | -$29.5K | -129 | -0.98% | $228.30 | 13K | Jun 25, 2024 | Direct | F2, F7 |
| transaction | ALNY | Common Stock | Sale | -$60.9K | -266 | -2.04% | $229.06 | 12.7K | Jun 25, 2024 | Direct | F2, F8 |
| transaction | ALNY | Common Stock | Sale | -$69.9K | -304 | -2.39% | $229.93 | 12.4K | Jun 25, 2024 | Direct | F2, F9 |
| transaction | ALNY | Common Stock | Sale | -$22.9K | -99 | -0.8% | $231.59 | 12.3K | Jun 25, 2024 | Direct | F2, F10 |
| transaction | ALNY | Common Stock | Sale | -$50.2K | -216 | -1.75% | $232.54 | 12.1K | Jun 25, 2024 | Direct | F2, F11 |
| transaction | ALNY | Common Stock | Sale | -$26.9K | -115 | -0.95% | $233.53 | 12K | Jun 25, 2024 | Direct | F2, F12 |
| transaction | ALNY | Common Stock | Sale | -$43.4K | -185 | -1.54% | $234.66 | 11.8K | Jun 25, 2024 | Direct | F2, F13 |
| transaction | ALNY | Common Stock | Sale | -$39.3K | -167 | -1.41% | $235.19 | 11.7K | Jun 25, 2024 | Direct | F2, F14 |
| Id | Content |
|---|---|
| F1 | On February 23, 2022, the reporting person was granted a performance-based stock unit (PSU) under the 2018 Stock Incentive Plan. The shares subject to the PSU vest based on the achievement of three specified performance measures. The shares reported were issued to the reporting person upon vesting of one-third of the shares subject to the PSU based on the issuer publicly reporting of a positive, statistically significant result on a clinical outcomes endpoint from a Phase 3 clinical study in ATTR amyloidosis with cardiomyopathy, as determined by The People, Culture and Compensation Committee of the Issuer Board of Directors on June 24, 2024. |
| F2 | Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form. |
| F3 | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $221.37 to $222.00. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F4 | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $223.92 to $224.43. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F5 | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $224.99 to $225.98. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F6 | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $226.45 to $227.35. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F7 | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $227.72 to $228.71. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F8 | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $228.75 to $229.72. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F9 | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $229.76 to $230.70. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F10 | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $230.92 to $231.78. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F11 | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $231.97 to $232.97. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F12 | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $233.00 to $234.00. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F13 | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $234.06 to $235.04. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F14 | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $235.10 to $235.73. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |